AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3525423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 29016867 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to M1 + PES to the back muscles
Number of subjects: 20
Study 29016867 — intervention group
Group type: EXPERIMENTAL
Intervention: PES
Number of subjects: 20
Study 29016867 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined tDCS + PES
Number of subjects: 20
Study 29016867 — intervention group
Group type: COMPARATOR
Intervention: tDCS + sham PES
Number of subjects: 20
Study 29016867 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + PES
Number of subjects: 20
Study 29016867 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + sham PES
Number of subjects: 20
Study 28416838 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic‐assisted percutaneous sacroiliac screw internal fixations
Number of subjects: 12
Study 28416838 — intervention group
Group type: COMPARATOR
Intervention: Manual operation guided by fluoroscopy
Number of subjects: 12
Study 24734891 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (Lis)
Number of subjects: 0
Study 24734891 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart (Asp)
Number of subjects: 0
Study 24083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding assistance of moderate quality
Number of subjects: 256
Study 24083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable weight over 3 months
Number of subjects: 256
Study 24083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss over 3 months
Number of subjects: 256
Study 24083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 256
Study 24083403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality risk
Number of subjects: 256
Study 21918241 — intervention group
Group type: COMPARATOR
Intervention: Pedometer 10,000 step goal
Number of subjects: 81
Study 21918241 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer step goal plus individualized motivational feedback
Number of subjects: 81
Study 21918241 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer step goal plus individualized motivational feedback and biweekly telephone feedback
Number of subjects: 81
Study 18431498 — intervention group
Group type: EXPERIMENTAL
Intervention: ART with 3 cycles of interleukin-2 (IL-2) (4.5 million IU sc BID x 5 days every 8 weeks)
Number of subjects: 47
Study 18431498 — intervention group
Group type: COMPARATOR
Intervention: ART without interleukin-2 (IL-2)
Number of subjects: 47
Study 17242485 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 12571667 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavone supplementation (Novasoy, 50 mg daily of isoflavone equivalents)
Number of subjects: 128
Study 12571667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 10627441 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA
Number of subjects: 18
Study 10627441 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 18
Study 8884705 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh-high antiembolic compression stockings (TED hose)
Number of subjects: 117
Study 8884705 — intervention group
Group type: COMPARATOR
Intervention: Antiembolic stockings and pneumatic compression stockings
Number of subjects: 117
Study 1575787 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly telephone contact by lay personnel
Number of subjects: 40
Study 3855339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd YAG laser
Number of subjects: 25
Study 3855339 — intervention group
Group type: COMPARATOR
Intervention: Argon laser
Number of subjects: 25
Study 31285208 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher empathy scores (middle tertile)
Number of subjects: 867
Study 31285208 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher empathy scores (highest tertile)
Number of subjects: 867
Study 31285208 — intervention group
Group type: COMPARATOR
Intervention: Lowest empathy scores (control group)
Number of subjects: 867
Study 27997877 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion (0.02 μg kg‐1 min‐1)
Number of subjects: 77
Study 27997877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 27129091 — intervention group
Group type: EXPERIMENTAL
Intervention: Total glucosides of paeony capsule (TGPC) combined with corticosteroids
Number of subjects: 81
Study 27129091 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids alone
Number of subjects: 81
Study 24674816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manipulation
Number of subjects: 30
Study 24674816 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 24674816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal manipulation
Number of subjects: 30
Study 22349843 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological rehabilitation (Rehacop)
Number of subjects: 93
Study 22349843 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy
Number of subjects: 93
Study 20509477 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxum (super oxidised water)
Number of subjects: 30
Study 20509477 — intervention group
Group type: COMPARATOR
Intervention: Betadine
Number of subjects: 30
Study 17955771 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (n = 30)
Number of subjects: 60
Study 17955771 — intervention group
Group type: COMPARATOR
Intervention: Albumin (n = 30)
Number of subjects: 60
Study 15886538 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehypertension
Number of subjects: 53163
Study 15886538 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 53163
Study 15886538 — intervention group
Group type: COMPARATOR
Intervention: Normal blood pressure
Number of subjects: 53163
Study 17176125 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa (Boostrix™)
Number of subjects: 4100
Study 10553817 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control of blood glucose with a standardized IV insulin infusion (Group TC)
Number of subjects: 20
Study 10553817 — intervention group
Group type: COMPARATOR
Intervention: No control of blood glucose (Group NC)
Number of subjects: 20
Study 10553817 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups experienced significant increases in blood glucose levels during hypothermic cardiopulmonary bypass
Number of subjects: 20
Study 10553817 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups experienced similar significant increases in postoperative serum levels of CK‐BB and S‐100 protein
Number of subjects: 20
Study 8705091 — intervention group
Group type: EXPERIMENTAL
Intervention: Policosanol 1 mg twice daily
Number of subjects: 23
Study 8705091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 1803333 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide‐eugenol (Cavitec)
Number of subjects: 21
Study 1803333 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide liner (Life)
Number of subjects: 21
Study 1803333 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide liner (Dycal)
Number of subjects: 21
Study 1803333 — intervention group
Group type: COMPARATOR
Intervention: Direct pulp capping agents (Life and Dycal)
Number of subjects: 21
Study 6601648 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaprim (RPM) - 450 mg RIF + 120 mg TMP twice daily
Number of subjects: 60
Study 6601648 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaprim (RPM) - 600 mg RIF + 160 mg TMP at bedtime
Number of subjects: 60
Study 6601648 — intervention group
Group type: COMPARATOR
Intervention: Rifaprim (RPM) - 800 mg SMZ + 160 mg TMP twice daily
Number of subjects: 60
Study 6601648 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (CO-T) - 800 mg SMZ + 160 mg TMP twice daily
Number of subjects: 60
Study 6601648 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (CO-T)
Number of subjects: 60
Study 6601648 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaprim (RPM)
Number of subjects: 60
Study 30095742 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia at 2100 m (FiO2: 0.18)
Number of subjects: 8
Study 30095742 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia at 1400 m (FiO2: 0.195)
Number of subjects: 8
Study 30095742 — intervention group
Group type: COMPARATOR
Intervention: Normoxia at 580 m (FiO2: 0.21)
Number of subjects: 8
Study 29941003 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthroposophic therapeutic speech (ATS), 11 sessions
Number of subjects: 63
Study 29941003 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 63
Study 27216134 — intervention group
Group type: EXPERIMENTAL
Intervention: DRV/r monotherapy (800/100 mg once daily for 48 weeks)
Number of subjects: 57
Study 27216134 — intervention group
Group type: EXPERIMENTAL
Intervention: DRV/r monotherapy
Number of subjects: 57
Study 27216134 — intervention group
Group type: COMPARATOR
Intervention: Atripla
Number of subjects: 57
Study 25247995 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTp-MQ (15 mg/kg)
Number of subjects: 1071
Study 25247995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1071
Study 22573627 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone (Amitiza) titrated up to 48 μg/day
Number of subjects: 54
Study 22573627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 22573627 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone
Number of subjects: 54
Study 20332739 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg.kg-1 + ketamine 0.5 mg.kg-1
Number of subjects: 72
Study 20332739 — intervention group
Group type: COMPARATOR
Intervention: Propofol 0.5 mg.kg-1 + ketamine 0.25 mg.kg-1
Number of subjects: 72
Study 17275763 — intervention group
Group type: COMPARATOR
Intervention: AV junction ablation
Number of subjects: 670
Study 17275763 — intervention group
Group type: COMPARATOR
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 670
Study 15632335 — intervention group
Group type: EXPERIMENTAL
Intervention: Atkins diet (carbohydrate restriction)
Number of subjects: 160
Study 15632335 — intervention group
Group type: EXPERIMENTAL
Intervention: Zone diet (macronutrient balance)
Number of subjects: 160
Study 15632335 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers diet (calorie restriction)
Number of subjects: 160
Study 15632335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornish diet (fat restriction)
Number of subjects: 160
Study 15632335 — intervention group
Group type: COMPARATOR
Intervention: All diets
Number of subjects: 160
Study 12077156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime 400 mg
Number of subjects: 6
Study 12077156 — intervention group
Group type: COMPARATOR
Intervention: Cefixime 400 mg
Number of subjects: 6
Study 10401916 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% CO2 inhalation
Number of subjects: 13
Study 10401916 — intervention group
Group type: COMPARATOR
Intervention: Compressed air inhalation
Number of subjects: 13
Study 7593425 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day
Number of subjects: 57
Study 30476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime sleep (measured in minutes)
Number of subjects: 195
Study 30476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary activity (measured in minutes)
Number of subjects: 195
Study 30476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-lagged effects of sleep on sedentary behavior
Number of subjects: 195
Study 30476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-lagged effects of sedentary behavior on sleep
Number of subjects: 195
Study 30476202 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-person standardized cross-lagged effects
Number of subjects: 195
Study 27991807 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual learning through a 3-day training session using an orientation discrimination task.
Number of subjects: 0
Study 27991807 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual learning for older adults.
Number of subjects: 0
Study 25688819 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 159
Study 25688819 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 159
Study 25688819 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 159
Study 23323897 — intervention group
Group type: EXPERIMENTAL
Intervention: 48-week ART
Number of subjects: 366
Study 23323897 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week ART
Number of subjects: 366
Study 23323897 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 366
Study 22464834 — intervention group
Group type: EXPERIMENTAL
Intervention: Question Prompt Lists (QPL)
Number of subjects: 0
Study 22464834 — intervention group
Group type: COMPARATOR
Intervention: Control group (no QPL)
Number of subjects: 0
Study 19111075 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS treatment (5 times per week for 4 weeks, 60 Hz, 100 microS, 25 mA, 20 minutes)
Number of subjects: 24
Study 19111075 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 24
Study 15975277 — intervention group
Group type: EXPERIMENTAL
Intervention: DC vaccine
Number of subjects: 30
Study 15975277 — intervention group
Group type: COMPARATOR
Intervention: Control (chemotherapy only)
Number of subjects: 30
Study 12464163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-free diet (diet 1; n = 19)
Number of subjects: 28
Study 12464163 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet including fish frozen for more than 48 hours (diet 2; n = 9)
Number of subjects: 28
Study 12464163 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with fresh fish (diet 3; n = 12)
Number of subjects: 28
Study 10485548 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized wedge-shaped defects of RNFL in the hemorrhage group (NTG and POAG)
Number of subjects: 83
Study 10485548 — intervention group
Group type: COMPARATOR
Intervention: Localized wedge-shaped defects of RNFL in NTG and POAG
Number of subjects: 83
Study 10485548 — intervention group
Group type: EXPERIMENTAL
Intervention: Location of disc hemorrhages
Number of subjects: 83
Study 8912771 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatic subjects (both atopic and nonatopic)
Number of subjects: 0
Study 8912771 — intervention group
Group type: COMPARATOR
Intervention: Controls (atopic and nonatopic)
Number of subjects: 0
Study 1655261 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril monotherapy, 10, 20, or 40 mg once daily
Number of subjects: 70
Study 1655261 — intervention group
Group type: COMPARATOR
Intervention: Captopril monotherapy, 25, 50, or 100 mg twice daily
Number of subjects: 70
Study 6603654 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim and methenamine hippurate (TMP + MH) at 100 + 500 mg b.i.d.
Number of subjects: 160
Study 6603654 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim and methenamine hippurate (TMP + MH) at 200 + 1000 mg b.i.d.
Number of subjects: 160
Study 6603654 — intervention group
Group type: COMPARATOR
Intervention: Plain Trimethoprim (TMP) at 200 mg b.i.d.
Number of subjects: 160
Study 6603654 — intervention group
Group type: COMPARATOR
Intervention: TMP-sulfamethoxazole combination at 160 mg + 800 mg b.i.d.
Number of subjects: 160
Study 30669665 — intervention group
Group type: EXPERIMENTAL
Intervention: High impact group (Zumba®)
Number of subjects: 55
Study 30669665 — intervention group
Group type: EXPERIMENTAL
Intervention: Low impact group (Aquagym)
Number of subjects: 55
Study 30346610 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of planned behavior (TPB)‐driven concussion education program
Number of subjects: 428
Study 30346610 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 428
Study 27829445 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention program integrating HIV-testing and treatment services, ECCD, and nutrition education for caregivers, consisting of nine group-based sessions over 12 weeks.
Number of subjects: 0
Study 27829445 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified in detail).
Number of subjects: 0
Study 24281754 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon (PCB) angioplasty
Number of subjects: 479
Study 22272347 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group undergoing a classical DRM design
Number of subjects: 60
Study 22272347 — intervention group
Group type: COMPARATOR
Intervention: Control group without DRM manipulation
Number of subjects: 60
Study 19661796 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast Cancer Education Intervention (BCEI) consisting of 3 face-to-face education and support sessions and 2 face-to-face and 3 telephone follow-up sessions over 6 months.
Number of subjects: 53
Study 19661796 — intervention group
Group type: COMPARATOR
Intervention: Wait-control group receiving 3 face-to-face sessions and 3 telephone sessions without the BCEI intervention.
Number of subjects: 53
Study 18380843 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond (SB) applied parallel to gravity (1A)
Number of subjects: 24
Study 18380843 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond (SB) applied perpendicular to gravity (1B)
Number of subjects: 24
Study 18380843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB2.1) applied parallel to gravity (2A)
Number of subjects: 24
Study 18380843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB2.1) applied perpendicular to gravity (2B)
Number of subjects: 24
Study 15942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-severe OSA (AHI >= 15)
Number of subjects: 49
Study 15942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild OSA (AHI 5-14)
Number of subjects: 49
Study 15942297 — intervention group
Group type: COMPARATOR
Intervention: Control (AHI <5)
Number of subjects: 49
Study 11914189 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 0
Study 11914189 — intervention group
Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 0
Study 10424180 — intervention group
Group type: EXPERIMENTAL
Intervention: Small capacity chainsaw
Number of subjects: 11
Study 10424180 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium capacity chainsaw
Number of subjects: 11
Study 10424180 — intervention group
Group type: EXPERIMENTAL
Intervention: Large capacity chainsaw
Number of subjects: 11
Study 7571047 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxifluridine
Number of subjects: 0
Study 7571047 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil with folinic acid
Number of subjects: 0
Study 2125242 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg once daily)
Number of subjects: 40
Study 2125242 — intervention group
Group type: COMPARATOR
Intervention: Oxiracetam (800 mg twice daily)
Number of subjects: 40
Study 2125242 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 40
Study 2125242 — intervention group
Group type: COMPARATOR
Intervention: Oxiracetam
Number of subjects: 40
Study 6778330 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral decongestant (pseudoephedrine hydrochloride)
Number of subjects: 50
Study 6778330 — intervention group
Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination (pseudoephedrine hydrochloride and chlorpheniramine maleate)
Number of subjects: 50
Study 6778330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31405402 — intervention group
Group type: EXPERIMENTAL
Intervention: GCBT plus duloxetine
Number of subjects: 170
Study 31405402 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine alone
Number of subjects: 170
Study 29444769 — intervention group
Group type: EXPERIMENTAL
Intervention: Living with Deadly Thoughts (online self-help intervention)
Number of subjects: 418
Study 29444769 — intervention group
Group type: COMPARATOR
Intervention: Living Well (attention-matched control program)
Number of subjects: 418
Study 26873498 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 20
Study 26873498 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 20
Study 25300435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiosphere-derived cells (CDCs)
Number of subjects: 0
Study 25300435 — intervention group
Group type: EXPERIMENTAL
Intervention: Depletion of CD90(+) cells
Number of subjects: 0
Study 25300435 — intervention group
Group type: EXPERIMENTAL
Intervention: CD90(‐) CDCs
Number of subjects: 0
Study 25300435 — intervention group
Group type: COMPARATOR
Intervention: c-kit(+) cells
Number of subjects: 0
Study 25300435 — intervention group
Group type: COMPARATOR
Intervention: c-kit expression
Number of subjects: 0
Study 22548300 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious video game designed to remediate attitudinal, behavioural and emotional processes
Number of subjects: 0
Study 22548300 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback component of the video game
Number of subjects: 0
Study 20109170 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement in the criminal justice system
Number of subjects: 609
Study 20109170 — intervention group
Group type: EXPERIMENTAL
Intervention: Victim of a crime
Number of subjects: 609
Study 20109170 — intervention group
Group type: EXPERIMENTAL
Intervention: On parole or probation
Number of subjects: 609
Study 20109170 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of involvement
Number of subjects: 609
Study 17081540 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tramadol
Number of subjects: 50
Study 17081540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17081540 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 16234105 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpikangfu decoction in combination with western medicine treatment
Number of subjects: 45
Study 16234105 — intervention group
Group type: COMPARATOR
Intervention: Exclusive western medicine treatment
Number of subjects: 45